J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India’s leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.
Financial Results:
J B Chemicals & Pharmaceuticals Ltd reported Revenues for Q4FY24 of ₹862.00 Crores up from ₹762.00 Crore year on year, a rise of 13.12%.
Total Expenses for Q4FY24 of ₹714.00 Crores up from ₹645.00 Crores year on year, a rise of 10.7%.
Consolidated Net Profit of ₹126.00 Crores up 43.18% from ₹88.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹8.13, up 43.64% from ₹5.66 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.